image missing

Central European Annals of Clinical Research

(ISSN: 2668-7305) Open Access Journal
Follow us:
Rss Feed:

Central European Annals of Clinical Research (CEACR) is no longer published on JAMS (the publishing platform provided by MDPI) as of 10.07.2021. The articles published until that date are archived at ceacr.archive.jams.pub by courtesy of JAMS.

Open Access
Endoped Abstract
CEACR 2020, 2(1), 37; doi: 10.35995/ceacr2010037

Craniopharyngioma and GH Therapy: “To Treat or Not To Treat?”

Cristina Preda , Letiția Leuștean * , Laura Teodoriu , Maria Christina Ungureanu
1 Department of Endocrinology, “Grigore T. Popa” University of Medicine and Pharmacy, 700111 Iași, Romania; (C.P.); (L.T.); (M.C.U.)
* Corresponding author:
* Author to whom correspondence should be addressed.
(this article belongs to the Special Issue ENDOPED International Congress 2020)
Received: 20 Oct 2020 / Revised: 13 Nov 2020 / Accepted: 14 Nov 2020 / Published: 17 Nov 2020
View Full-text Download PDF (170kb)
Keywords: craniopharingyoma; growth hormone; recurrences
OPEN ACCESS
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. (CC BY 4.0).
CITE
Preda, C.; Leuștean, L.; Teodoriu, L.; Ungureanu, M.C. Craniopharyngioma and GH Therapy: “To Treat or Not To Treat?”. CEACR 2020, 2, 37.
Preda C, Leuștean L, Teodoriu L, Ungureanu MC. Craniopharyngioma and GH Therapy: “To Treat or Not To Treat?”. Central European Annals of Clinical Research. 2020; 2(1):37.
Preda, Cristina; Leuștean, Letiția; Teodoriu, Laura; Ungureanu, Maria Christina. 2020. "Craniopharyngioma and GH Therapy: “To Treat or Not To Treat?”." CEACR 2, no. 1: 37.
Not implemented
SHARE